PRESS RELEASE published on 01/17/2024 at 12:00, 1 year 10 months ago UTILITY therapeutics Ltd. Announces Financing Led by the AMR Action Fund and FDA Acceptance of PIVYA New Drug Application with Priority Review UTILITY therapeutics Ltd. announces a private financing led by the AMR Action Fund and the U.S. FDA's acceptance of its New Drug Application (NDA) for PIVYA, a European-approved antibiotic for the treatment of uncomplicated urinary tract infections (UTIs). PIVYA has received the FDA's qualified infectious disease product (QIDP) designation, providing an additional 5 years of market exclusivity upon approval. This new antibiotic offers a unique mechanism of action and aims to address the rising rates of antimicrobial resistance. For more information, visit www.utilitytherapeutics.com. UTILITY Therapeutics PIVYA Urinary Tract Infections Antibiotic FDA Approval
Published on 12/16/2025 at 13:00, 11 minutes ago Abasca Resources Provides Exploration Update at its Loki Flake Graphite Deposit and Granting Stock Option
Published on 12/16/2025 at 13:00, 11 minutes ago Silver Wolf Completes Acquisition of the Ana Maria Project
Published on 12/16/2025 at 12:00, 1 hour 11 minutes ago Tokenwell Plans to Establish U.S. Subsidiary in Dallas, Texas, to Expand its Presence in the Growing Digital Asset Hub
Published on 12/16/2025 at 12:00, 1 hour 11 minutes ago CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
Published on 12/16/2025 at 12:00, 1 hour 11 minutes ago Snowline Gold Awards Key Contracts and Commences Prefeasibility Study on its Flagship Rogue Project, Yukon
Published on 12/16/2025 at 12:55, 16 minutes ago Banyan Group's Garrya Mu Cang Chai Opens in a National Heritage Site in Northern Vietnam
Published on 12/16/2025 at 12:22, 48 minutes ago REPLOID Group AG: HEROSAN launches crowdfunding campaign
Published on 12/16/2025 at 12:05, 1 hour 6 minutes ago BRP Announces Appointment of Denis Le Vot as President and Chief Executive Officer
Published on 12/16/2025 at 12:00, 1 hour 11 minutes ago DATAGROUP initiates delisting procedure on the Munich Stock Exchange
Published on 12/16/2025 at 11:49, 1 hour 21 minutes ago Strategic Investment: CANSOUL acquires stake in SYNBIOTIC
Published on 12/16/2025 at 08:30, 4 hours 41 minutes ago Cie du Bois Sauvage: Buy back of own shares – week from 08/12/2025 to 12/12/2025
Published on 12/15/2025 at 22:36, 14 hours 35 minutes ago Disclosure of trading in own shares between December 1st and December 5th, 2025
Published on 12/15/2025 at 18:30, 18 hours 41 minutes ago MCH PRIVATE EQUITY AND EURAZEO ENTER INTO AN EXCLUSIVE AGREEMENT WITH ARDIAN FOR THE SALE OF THEIR MAJORITY STAKE IN FERMAX
Published on 12/15/2025 at 18:05, 19 hours 6 minutes ago Covivio - Treasury shares transactions between December 8th , 2025 and December 12th, 2025
Published on 12/15/2025 at 17:45, 19 hours 26 minutes ago ENGIE strengthens the resilience of the Belgian electricity system with new flexible capacities